ARNOLD KLING
August 14, 2011
The Top Political Contributors
August 11, 2011
Gender and the New Commanding Heights
August 11, 2011
Jamie Galbraith Makes an Assumption
August 11, 2011
Macroeconometrics: The Science of Hubris
August 10, 2011
Real and Nominal Bond Yields
BRYAN CAPLAN
August 14, 2011
The Effect of Thumb Sucking on Income
August 12, 2011
The Voice of Cold, Hard Truth to All Would-Be Educators
August 12, 2011
Ability, Morality, and Prosperity: A Paper and a Report
August 11, 2011
The Theory of Time and Frittering
August 10, 2011
Male Variance and the Remnants of the Gender Gap
DAVID HENDERSON
August 9, 2011
Hayek in "Unbroken", Part Two
August 8, 2011
Hayek in "Unbroken"
August 5, 2011
James Bovard on the Peace Corps
August 4, 2011
Summers Way Off on FDR and 1941
August 3, 2011
The "Amazon" Tax


I really hope the healthcare debate will be made available in some form on the web.
If you're coming to the Seasteading event at Cato, sign up here: http://www.cato.org/event.php?eventid=5747
The event goes from 12noon to 1:30pm.
A complimentary lunch will be served afterward.
The article on health care says:
Prostate cancer mortality is 604 percent higher in the U.K. and 457 percent higher in Norway.
Uh, 6.04 and 4.57 times our rate? That suggests to me that something fishy is going on.
For the sake of argument, assume there's absolutely nothing anybody can do to treat prostate cancer: either it kills you, or it doesn't, but we can't affect the outcome. You will die of it with 1:n odds.
Now assume country A screens for prostate cancer, and country B doesn't. (And the screen is of everyone, and it's perfectly accurate.) The mortality rate for prostate cancer in country A will be 1/(n+1) (i.e. (100/(n+1))%).
But in country B, you only get diagnosed with prostate cancer when it's bad enough that it kills you. The mortality rate for prostate cancer in country B will be 1/1 = 100%.
Country A is no better at treating prostate cancer than country B (by assumption), but because they screen for it, their mortality stats look better (a lot better, for n > .5 or so).
While I dread the thought of an American NHS, and am quite willing to believe we're better at treating cancer, I think the above screening phenomenon accounts for an awful lot of our measured superiority in treating some conditions.
(I will now attempt to go the rest of 2009 without saying "prostate cancer".)